Levine Cancer Institute - Charlotte

Charlotte, North Carolina 28204-2990

1 studies enrolling now · 2 studies all time

What they study most

Advanced Cholangiocarcinoma, EGFR/HER2 Exon 20 Insertion Mutation, FGFR2 Gene Mutation, NSCLC, Non-Small Cell Lung Cancer

Studies at this site

• First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations — Recruiting now
• Phase 3 Study of BGJ398 (Oral Infigratinib) in First Line Cholangiocarcinoma With FGFR2 Gene Fusions/Translocations — Stopped early